首页> 美国卫生研究院文献>Immunology >Modulation of cell-bound and soluble CD23 spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
【2h】

Modulation of cell-bound and soluble CD23 spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

机译:通过可溶性IL-4受体和部分拮抗性IL-4突变蛋白IL-4(Y124D)调节细胞结合和可溶性CD23人外周血单核细胞的自发性和正在进行的IgE合成。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We studied the influence of human recombinant soluble interleukin-4 receptors (sIL-4R) and a partial antagonistic mutant IL-4 protein, IL-4(Y124D), on the in vitro CD23 expression, soluble (s)CD23 release and IgE synthesis of human peripheral blood mononuclear cells (PBMC). The data show that sIL-4R suppressed the IL-4-induced IgE synthesis of PBMC. sIL-4R fusion protein stabilized with human Fc gamma fragments showed a more pronounced effect than unconjugated sIL-4R. IL-4(Y124D) also suppressed the IL-4-induced IgE synthesis. The IL-4-induced antigen CD23 and its soluble fragments were suppressed by sIL-4R and IL-4(Y124D). PBMC of atopic donors with a spontaneous in vitro IgE synthesis showed a partial suppression of the IgE production after sIL-4R or IL-4(Y124D) application. The IgE synthesis and sCD23 release of normal donor PBMC were suppressed when the substances were applied 0-4 days after IL-4 treatment. After 4 days of IL-4 stimulation, sIL-4R and IL-4(Y124D) enhanced the IgE synthesis. These data demonstrate that sIL-4R and IL-4(Y124D) are suppressive for the primary IgE synthesis induced by IL-4. In contrast, the ongoing IgE synthesis was only partially modulated by sIL-4R and IL-4(Y124D), and in some conditions even an enhancement of the IgE production was observed. These data suggest a differential function for IL-4 in the early and late phase of PBMC IgE production.
机译:我们研究了人类重组可溶性白介素4受体(sIL-4R)和部分拮抗突变体IL-4蛋白IL-4(Y124D)对体外CD23表达,可溶性(s)CD23释放和IgE合成的影响人外周血单核细胞(PBMC)的数量。数据显示,sIL-4R抑制了IL-4诱导的PBMC的IgE合成。用人Fcγ片段稳定的sIL-4R融合蛋白比未结合的sIL-4R表现出更明显的作用。 IL-4(Y124D)也抑制IL-4诱导的IgE合成。 IL-4诱导的抗原CD23及其可溶性片段被sIL-4R和IL-4(Y124D)抑制。应用sIL-4R或IL-4(Y124D)后,具有自发体外IgE合成功能的特应性供体的PBMC表现出对IgE产生的部分抑制。当在IL-4处理后0-4天施用该物质时,正常供体PBMC的IgE合成和sCD23释放被抑制。 IL-4刺激4天后,sIL-4R和IL-4(Y124D)增强了IgE的合成。这些数据表明,sIL-4R和IL-4(Y124D)抑制由IL-4诱导的初级IgE合成。相反,正在进行的IgE合成仅受sIL-4R和IL-4(Y124D)的部分调节,在某些情况下甚至观察到IgE产量增加。这些数据表明在PBMC IgE产生的早期和晚期,IL-4的功能有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号